BioSino is a leading high-technology enterprise whose major national controlling stakeholders comprise the Chinese Academy of Sciences, Beijing Municipal Government and Shanghai Municipal Government. Biosino has already become the largest manufacturer of IVD reagents in China after 20 years development. BioSino successfully finished IPO in GEM of Hong Kong Stock in 2006. Biosino's diagnostic products including clinical chemistry, immunology assay, molecular diagnostics, and rapid tests. BioSino has developed over 600 distributors and retailers over the China, occupy 75% of the Chinese market. The diagnostic products exported to over 50 countries from Southeast Asia, Middle-east, North Africa, and South America. BioSino has a professional after sales service team comprising experts in the field of biochemistry, immunology, pharmacy and medicine. It provide on-the-spot technological support and service to our customers, teach them how to use our products and resolve problems they meet.